Prot #APL9-COV-201: A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel-Group Study of APL-9 in Mild to Moderate Acute Respiratory Distress Syndrome Due to COVID-19

Project: Research project

Project Details

StatusActive
Effective start/end date6/26/206/26/23

Funding

  • Worldwide Clinical Trials, Inc. (Prot #APL9-COV-201)
  • Apellis Pharmaceuticals, Inc. (Prot #APL9-COV-201)